Literature DB >> 2889376

Sustained remission in drug-free schizophrenic patients.

W S Fenton1, T H McGlashan.   

Abstract

The inability to determine which schizophrenic patients do not require maintenance medication is a significant gap in current knowledge. This report describes 23 largely chronic DSM-III schizophrenic patients who, after a period of inpatient treatment, sustained good outcome without maintenance antipsychotic medication over an average of 15 years. Retrospective study of these patients revealed that their distinguishing characteristics at admission included better premorbid social and occupational adjustment, higher levels of accrued psychosocial competence and acquired skills, fewer hebephrenic traits, and the preservation of affect (depressed mood). Hence, even within a largely chronic patient sample, classic predictors of good outcome may also be useful in predicting sustained remission without medication.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889376     DOI: 10.1176/ajp.144.10.1306

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

1.  Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut Lodge.

Authors:  Thomas H McGlashan; William T Carpenter
Journal:  Schizophr Bull       Date:  2007-07-18       Impact factor: 9.306

Review 2.  Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

3.  A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Authors:  Martin Harrow; Thomas H Jobe; Robert N Faull; Jie Yang
Journal:  Psychiatry Res       Date:  2017-06-22       Impact factor: 3.222

4.  Influence of duration of untreated psychosis on the short-term outcome of drug-free schizophrenia patients.

Authors:  Mariyamma Philip; Bn Gangadhar; Latha Velayudhan; D K Subbakrishna
Journal:  Indian J Psychiatry       Date:  2003-07       Impact factor: 1.759

5.  How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up.

Authors:  Martin Harrow; Thomas H Jobe
Journal:  Schizophr Bull       Date:  2008-07-09       Impact factor: 9.306

6.  Developmental and neurologic correlates of treatment response in schizophrenia.

Authors:  C L Whelton; J M Cleghorn; S Atley; G J Durocher; D MacCrimmon
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

7.  Neuropsychological correlates of remission in chronic schizophrenia subjects: The role of general and task-specific executive processes.

Authors:  Thais Rabanea-Souza; Henrique T Akiba; Arthur A Berberian; Rodrigo A Bressan; Álvaro M Dias; Acioly L T Lacerda
Journal:  Schizophr Res Cogn       Date:  2016-02-16

8.  Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series.

Authors:  Hideaki Tani; Masayuki Tomita; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-11-30       Impact factor: 2.582

Review 9.  Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.

Authors: 
Journal:  Int J Neuropsychopharmacol       Date:  2022-09-28       Impact factor: 5.678

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.